{"name":"Dr Madeleine Wilwerth","slug":"dr-madeleine-wilwerth","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Levobupivacaine 0.07% + Sufentanil 0.3µg/ml","genericName":"Levobupivacaine 0.07% + Sufentanil 0.3µg/ml","slug":"levobupivacaine-0-07-sufentanil-0-3-g-ml","indication":"Regional anesthesia and analgesia for epidural administration","status":"phase_3"},{"name":"Levobupivacaine 0.1% + Sufentanil 0.2µg/ml","genericName":"Levobupivacaine 0.1% + Sufentanil 0.2µg/ml","slug":"levobupivacaine-0-1-sufentanil-0-2-g-ml","indication":"Regional anesthesia and analgesia (epidural administration)","status":"phase_3"}]}],"pipeline":[{"name":"Levobupivacaine 0.07% + Sufentanil 0.3µg/ml","genericName":"Levobupivacaine 0.07% + Sufentanil 0.3µg/ml","slug":"levobupivacaine-0-07-sufentanil-0-3-g-ml","phase":"phase_3","mechanism":"Levobupivacaine blocks sodium channels to provide local anesthesia, while sufentanil activates opioid receptors to provide analgesia, together delivering regional anesthesia and pain relief.","indications":["Regional anesthesia and analgesia for epidural administration","Postoperative pain management via epidural infusion"],"catalyst":""},{"name":"Levobupivacaine 0.1% + Sufentanil 0.2µg/ml","genericName":"Levobupivacaine 0.1% + Sufentanil 0.2µg/ml","slug":"levobupivacaine-0-1-sufentanil-0-2-g-ml","phase":"phase_3","mechanism":"Levobupivacaine blocks sodium channels to provide local anesthesia, while sufentanil activates opioid receptors to provide analgesia, together delivering regional anesthesia and pain relief.","indications":["Regional anesthesia and analgesia (epidural administration)","Perioperative pain management"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}